News | Contrast Media | July 12, 2016

ACR Manual on Contrast Media Addresses FDA Gadolinium Safety Concerns

Updated resource for radiologists guides safe, effective use of contrast media in daily practice

gadolinium, ACR Manual on Contrast Media, update, FDA safety concerns

July 12, 2016 — The updated American College of Radiology (ACR) Manual on Contrast Media contains a statement addressing the U.S. Food and Drug Administration (FDA) safety communication on use of gadolinium-based contrast agents for magnetic resonance imaging (MRI).

Gadolinium-based contrast agents are administered to approximately 30 million patients every year to improve the diagnostic accuracy of MR examinations. Researchers have found that gadolinium-based contrast agents may leave deposits in the brain, bone and other organs. “If the decision is made to use a gadolinium-based contrast agent for an MRI study for an individual patient, multiple factors need to be considered … including diagnostic efficacy, relaxivity, rate of adverse reactions, dosing/concentration and propensity to deposit in more sensitive organs, such as the brain,” notes a joint statement from the ACR and the American Society of Neuroradiology (ASNR).

“This vital guide for radiologists enhances the safe and effective use of contrast media in daily practice to ensure optimal patient care,” said Jacqueline Bello, M.D., FACR, chair of the ACR Commission on Quality and Safety. “The timely inclusion of the ACR and ASNR joint statement addresses questions posed by many radiology professionals about gadolinium-based contrast agents in the previous months,” she added.

“Reviews from radiologists show that this reference on contrast media is a practical and valuable resource in support of the millions of radiological examinations that may be assisted by intravascular contrast media annually,” said James H. Ellis, M.D., FACR, chair of the ACR Committee on Drugs and Contrast Media. He noted that the manual continues to be available for free as a frequently updated downloadable document on the ACR website.

Version 10.2 of the resource for using contrast media in diagnostic imaging includes:

  • An updated footnote in “Metformin,” concerning the FDA’s April 2016 guidance on patients who take this medication and who receive iodinated contrast media;
  • Information and new references about intra-osseous injection in “Injection of Contrast Media”; and
  • The addition of a document version history, so users may track changes from version to version.

 

Related Gadolinium Safety Concern Articles

Gadolinium May Remain in Brain after Contrast MRI

MRIs During Pregnancy Are Safe, But Gadolinium Scans May Increase Risk to Fetus

Study Finds No Association Between Gadolinium Contrast and Nervous System Disorder

Even High Doses of Gadolinium-Based Contrast Agents Doesn't Cause NSF

 

For more information: www.acr.org

Related Content

Prenatal MRI of a Zika fetus showing enlarged cerebral fluid space, dilation of the cerebral ventricles, thinning of brain tissue, poorly developed cerebellum and the absence of brain cortical gyri. (Image coutesy of RSNA)

Feature | Women's Health | January 23, 2017 | Dave Fornell
The rapid spread of Zika virus in the Western Hemisphere this past year has caused great alarm in the United States,
Iradimed, FDA clearance, MRIdium 3860+ IV infusion pump system, MRI-compatible,
Technology | Magnetic Resonance Imaging (MRI) | January 17, 2017
Iradimed Corp. announced in December that it received U.S. Food and Drug Administration (FDA) 510(k) clearance for its...
Siemens, Biogen, joint development, MRI tools, multiple sclerosis
News | Neuro Imaging | January 17, 2017
January 17, 2017 — Siemens Healthineers and Biogen have announced the companies plan to jointly develop...
MRgFUS
News | Focused Ultrasound Therapy | January 17, 2017
Insightec, a leader in MR-guided focused ultrasound (MRgFUS) therapy, announced today that the Japanese Ministry of...
MIM Software, BK Ultrasound, bkFusion, MRI Fusion Biopsy System, prostate cancer, RSNA 2016
Technology | Fusion Imaging Software | January 03, 2017
MIM Software Inc. announced in November the commercial introduction of its MRI (magnetic resonance imaging) Prostate...
Philips, e-Alert, MRI, Most Innovative IoT Solution Award, World Communication Awards
News | Magnetic Resonance Imaging (MRI) | January 03, 2017
Royal Philips recently announced that its e-Alert was awarded “Most Innovative IoT Solution” at the World Communication...
pregnancy brain, pregnant brain, pregnancy's effect on the brain

An image from the study showing brain volume changes in women post pregnancy. Image by Oscar Vilarroya.

 

 

News | Magnetic Resonance Imaging (MRI) | December 28, 2016
December 28, 2016 — Pregnancy involves radical hormone surges and biological adaptations, but the effects on the brai
MRI-guided focused ultrasound
News | Focused Ultrasound Therapy | December 22, 2016
Insightec Ltd. announced that the Exablate Prostate system received CE Mark for treating locally-confined prostate...
MRI brain
Feature | Magnetic Resonance Imaging (MRI) | December 22, 2016
If you're thinking about taking up running as your New Year's resolution and still need some convincing, consider this...
MRI advances, innovations in MRI, most popular radiology stories
Feature | December 20, 2016 | Dave Fornell
The Imaging Technology News (ITN) website had a record year with more than 1.04 million page views in 2016.
Overlay Init